1 |
Heiss WD, Podreka I, 'Role of PET and SPECT the assessment of ischemic derebro vascular disease' cerebrovasc Brain Metab Rev. vol 5, pp. 235-263, 1993
|
2 |
Touho H, Karasawa J, Ohnishi H, 'Preoperative and postperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease', Stroke vol.27, pp. 282-289, 1996
DOI
|
3 |
Lassen NA. 'Cerebral blood flow and oxygen consumption in man', Physiol. rev. vol. 39. pp. 183-238, 1959
DOI
|
4 |
이상경, '경색성 뇌혈관질환의 임상적 분석', 학위논문(석사)중앙대학교 대학원, pp. 39-42, 1989
|
5 |
Cikrit DF, Burt RW, Dalsing MC, Lalka SG, Sawchuk AP, Waymire B, 'Acetazolamide enhanceds ingle photon emission computed tomography evaluation of cerebral perfusion before and after carotid endarteretomy', J Vasc Surg vol.15, pp. 747-753, 1992
DOI
|
6 |
尹亭九, 'Ascorbic Acid가 자발성 고혈압백서의 혈압에 미치는 영향', 학위논문(석사)한양대학교 대학원, pp. 46-48, 1980
|
7 |
Shinoda, J. Kimura,T. Funakoshi, T. Araki, Y, 'Acetazolamide reactivity on cerebral blood flow in patients with subarachnoid haemorrhage', Acta Neurochir Wien, vol.109, pp. 102-108, 1991
DOI
|
8 |
Gibbs JM, Wise RJS, Leenders KL, Jones T, 'Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion', Lancet vol.11, pp. 310-314, 1984
DOI
ScienceOn
|
9 |
BonteF J. Devous,MD, Sr, Reisch JS, Ajmani AK, 'The effect of acetazolmide on regional cerebral blood flow in patients with Alzheimer's disease or stroke a measured by single-photon emission computed tomography', Invest Radiol, vol. 24, pp. 99-103, 1989
DOI
|